Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 73

Results For "ISA"

1072 News Found

Bronchoscopic Thermal Vapor Ablation (BTVA): A new ray of hope for COPD patients
Hospitals | March 31, 2022

Bronchoscopic Thermal Vapor Ablation (BTVA): A new ray of hope for COPD patients

Yashoda Hospitals Hyderabad has earned the distinction of becoming the first to introduce BTVA in India


We have built new AI platforms like REILI to meet current needs: Chander Shekhar Sibal, Sr. Vice-President, Fujifilm India
interviews | March 30, 2022

We have built new AI platforms like REILI to meet current needs: Chander Shekhar Sibal, Sr. Vice-President, Fujifilm India

Fujifilm has been at the forefront of medical imaging and healthcare informatics. It’s developing new AI platforms to address medical challenges. Chander Shekhar Sibal, Sr. Vice-President, Fujifilm India gives us an insight in an interview with Thomas C. Thottathil, Editor, indianpharmapost.com


TDB approves funding for MIM in MedTech
News | March 30, 2022

TDB approves funding for MIM in MedTech

Technology Development Board supports commercialisation of Metal Injection Molding of implants


SRV Hospitals and Lokmanya Hospital launch centre for robotic orthopaedics
Hospitals | March 30, 2022

SRV Hospitals and Lokmanya Hospital launch centre for robotic orthopaedics

The SRV LHPL centre of excellence in robotic orthopaedics will be helmed by joint replacement surgeon, Dr Narendra Vaidya


Ondexxya approved in Japan for reversal of acute major bleeds in patients on Factor Xa inhibitors
Drug Approval | March 30, 2022

Ondexxya approved in Japan for reversal of acute major bleeds in patients on Factor Xa inhibitors

Ondexxya is the first approved reversal agent specifically for Factor Xa inhibitors, providing a major advance in the treatment of patients hospitalised with life-threatening bleeding


Medtronic commences PRAAN registry for stroke patients
Medical Device | March 30, 2022

Medtronic commences PRAAN registry for stroke patients

The registry will be conducted for approximately two and a half years and up to 200 subjects will be enrolled


OPPI summit calls for collaboration across stakeholders
News | March 30, 2022

OPPI summit calls for collaboration across stakeholders

The summit also saw the launch of two important reports- Multi-Regional Clinical Trials (MRCT) and Value of OTC in India


Sun Pharma gets exclusive patent licence for Vortioxetine
News | March 30, 2022

Sun Pharma gets exclusive patent licence for Vortioxetine

Vortioxetine is a novel antidepressant with multimodal activity, which is approved to treat Major Depressive Disorder (MDD) in adults


Alembic Pharma acquires 100% stake in Aleor Dermaceuticals
News | March 29, 2022

Alembic Pharma acquires 100% stake in Aleor Dermaceuticals

The amalgamation will integrate business operations and provide impetus to the existing portfolio of Alembic


EU approves Evusheld to prevent Covid-19
Drug Approval | March 28, 2022

EU approves Evusheld to prevent Covid-19

Evusheld significantly reduced the risk of developing symptomatic COVID-19 in PROVENT Phase III trial, with protection lasting at least six months